According to our latest study, titled “Human Identification Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Services, Technology, Application, and End User,” the global human identification market is expected to grow from 1,827.02 million in 2021 to US$ 3,900.24 million by 2028. It is estimated to grow at a CAGR of 11.4% from 2021 to 2028.
The government initiatives for forensic programs and the novel sampling methods and portable equipment supporting DNA phenotyping, immunochromatography, geolocation, and other advanced forensic techniques are contributing to the human identification market growth. However, the high cost associated with instruments used in genomic studies restrain the human identification market growth.
As the crisis moved forward, healthcare professionals realized that developing novel therapies using innovative technologies was essential to mitigate this unprecedented crisis.
The treatment against COVID 19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the genome editing-related market as US FDA has recently approved the use of plasma therapy for critically ill COVID 19 patients. upcoming stem cell therapies to boost patients’ immune systems and eliminate the virus will offer significant growth prospects for the market. For instance, Lattice Biologics, in collaboration with Alumina Partners, has been accelerating phase 1 clinical trials for its stem cell-based AminioBoost therapies of COVID-19. Moreover, the mRNA-based vaccines against the COVID19 have been given emergency use authorization by the regulatory agencies in the region. The active involvement of the government and the associated market players in exploring opportunities for genome editing-related products and services is expected to drive such developments which will add to the future demand for the human identification market in the forecast period.
Manufacturers are bringing innovative products to the human identification market through various collaborations. For instance, in January 2022, the QIAGEN announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set new standards by using so-called nanoplates to process samples in two hours rather than the five hours required by other systems.
Thermo Fisher Scientific Inc.; Promega Corporation; Bio-Rad Laboratories, Inc.; QIAGEN; General Electric Company; llumina, Inc.; Eurofins Scientific; Agilent Technologies, Inc.; Hamilton Company; and LGC Limited are a few leading companies operating in the global human identification market.
The report segments the human identification market as follows:
Based on products and services, the human identification market is segmented into consumables, services, instruments, and software. The consumables segment is further categorized into electrophoresis kits and reagents, DNA amplification kits and reagents, DNA quantification kits and reagents, DNA extraction kits and reagents, and rapid DNA analysis kits and reagents. The consumables segment led the global market in 2021 and is anticipated to register the highest CAGR of 11.9% during the forecast period.
By technology, the market is segmented into capillary electrophoresis, polymerase chain reaction, nucleic acid purification and extraction, automated liquid handling, microarrays, next-generation sequencing, and rapid DNA analysis. The capillary electrophoresis segment dominated the global market in 2021. However, the polymerase chain reaction segment is anticipated to register the highest CAGR of 12.0% in the market during the forecast period.
By application, the market is segmented into forensic applications, paternity identification, and other applications. The forensic application segment held the largest market share in 2021 and is anticipated to register a CAGR of 12.0% in the market during the forecast period.
Based on end user, the global market is segmented into forensic laboratories, research and academic centers, and government institutes. The forensic laboratories segment accounted for the largest share of the market in 2021. It is estimated to register the highest CAGR of 11.9% during the forecast period.
Based on geography, the human identification market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America (SCAM). The North America market is segmented into the US, Canada, and Mexico. The Europe market is segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The APAC market is segmented Into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The MEA market is segmented Into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The SCAM is segmented into Brazil, Argentina, and the Rest of South and Central America.
|
TIP is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
|
|
Contact Us: |
|
If you have any queries about this report or if you would like further information, please contact us: |
|
Contact Person: Ankit Mathur |
|
E-mail: [email protected] |
|
Phone: +1-646-491-9876 |
About Author
